Natixis Advisors’s Covetrus, Inc. Common Stock CVET Stock Holding History

Natixis Advisors’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-23,626	Closed	-$493K	–	1537
2022 Q3	$493K	Sell	23,626 -1,923	-8%	-$40K	﹤0.01%	1287
2022 Q2	$530K	Buy	25,549 +11,172	+78%	+$199K	﹤0.01%	1265
2022 Q1	$241K	Buy	+14,377	New	+$251K	﹤0.01%	1405
2021 Q3	–	Sell	-12,825	Closed	-$346K	–	1368
2021 Q2	$346K	Sell	12,825 -924	-7%	-$25.9K	﹤0.01%	1262
2021 Q1	$412K	Sell	13,749 -800	-5%	-$27.3K	﹤0.01%	1192
2020 Q4	$418K	Sell	14,549 -23	-0.2%	-$621	﹤0.01%	1141
2020 Q3	$356K	Buy	+14,572	New	+$314K	﹤0.01%	1098

Other funds holding CVET

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Natixis Advisors's CVET Position: Q4 2022 in Review

Natixis Advisors sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 23,626 shares — an estimated $493K sold.

Natixis Advisors first reported a position in CVET in Q3 2020 and held it in 7 quarters. The position peaked at $530K in Q2 2022. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

Natixis Advisors reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Natixis Advisors sold 23,626 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $493K.
Natixis Advisors first reported a position in Covetrus, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
Natixis Advisors's Covetrus, Inc. Common Stock position peaked at $530K in Q2 2022.
5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Natixis Advisors's 13F filing for Q4 2022, filed 27 Jan 2023.